Neurocrine Biosciences (NBIX) Work In Process (2017 - 2025)
Neurocrine Biosciences (NBIX) posted quarterly Work In Process of $13.8 million for Q1 2025, up 15.0% year-over-year from $12.0 million in Q1 2024, and up 26.61% on a QoQ basis from $10.9 million in Q4 2024.
Neurocrine Biosciences (NBIX) Work In Process (2017 - 2025) Analysis & Trends
Neurocrine Biosciences has reported Work In Process for 9 years, with the latest figure at $13.8 million in Q1 2025.
- Work In Process for Q1 2025 came in at $13.8 million, up 15.0% year-over-year; the trailing twelve-month figure through Mar 2025 was $13.8 million (up 15.0% YoY), and the FY2024 annual result was $10.9 million, up 12.37% from the prior year.
- Work In Process rose to $13.8 million in Q1 2025, from $10.9 million in the prior quarter.
- Over five years, Work In Process peaked at $13.8 million in Q1 2025 and troughed at $3.6 million in Q4 2021.
- A 5-year average of $9.8 million and a median of $10.8 million in 2024 frame the typical range for Work In Process.
- The widest annual swing landed in 2023, when Work In Process soared 73.21%; it then gained 12.37% in 2024.
- A 5-year view of Work In Process shows it stood at $3.6 million in 2021, then surged by 55.56% to $5.6 million in 2022, then jumped by 73.21% to $9.7 million in 2023, then gained by 12.37% to $10.9 million in 2024, then gained by 26.61% to $13.8 million in 2025.
- Per Business Quant data, the three most recent Work In Process figures were $13.8 million in Q1 2025, $10.9 million in Q4 2024, and $10.6 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 13.80 Mn |
| Dec 31, 2024 | 10.90 Mn |
| Sep 30, 2024 | 10.60 Mn |
| Jun 30, 2024 | 12.00 Mn |
| Mar 31, 2024 | 12.00 Mn |
| Dec 31, 2023 | 9.70 Mn |
| Dec 31, 2022 | 5.60 Mn |
| Dec 31, 2021 | 3.60 Mn |
| Dec 31, 2020 | 2.40 Mn |
| Mar 31, 2020 | 1.10 Mn |
| Dec 31, 2019 | 1.50 Mn |
| Sep 30, 2019 | 2.25 Mn |
| Jun 30, 2019 | 3.45 Mn |
| Mar 31, 2019 | 4.46 Mn |
| Dec 31, 2018 | 2.21 Mn |
| Sep 30, 2018 | 270,000.00 |
| Dec 31, 2017 | 491,000.00 |